SOHO 2022 Tenth Annual Meeting


 

SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab Monotherapy for Patients With R/R FL Who Have Received ≥2 Prior Lines of Therapy

33 views
October 14, 2022
0 Comments
Login to view comments. Click here to Login
Lymphoma